Advance Your Biotech With NCI SBIR Funding and Resources
Are you aware of the federal funding program that supports the commercialization efforts of biotech innovators? The Small Business Research (SBIR) program at the National Cancer Institute (NCI) provides up to $6.4 million in funding to life science startups (per project) with no strings attached.
As part of NCI’s engine of innovation for advancing novel cancer-related technologies from lab to market, the SBIR Development Center funds a diverse portfolio of small businesses that are developing technologies to prevent, diagnose, and treat cancer.
To learn more, join NCI SBIR and Princeton Innovation Center BioLabs for a nationwide informative virtual session on Wednesday, August 6, from 12:30–2:30 pm EDT.
Topics to be covered include:
• New and current funding opportunities
• Application tips and suggestions
• Commercialization resources for applicants and awardees
After the presentation, attendees will have a chance to participate in a Fireside Chat and schedule one-on-one virtual meetings with NCI SBIR Program Director Sarra Djemil to discuss their cancer technology project and funding eligibility. To be considered for a one-on-one meeting, please reach out to Michelle Roemer-Schoen with a one-page technology summary or specific aims page on your technology by Monday, July 28.
For questions about this event, please email Michelle Roemer-Schoen. We look forward to seeing you online!
The Zoom link will be sent to you in a separate email a few days before the event.